Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03130803 · ClinicalTrials.gov registry record · NA
Biomarkers of Insufficient Sleep and Sleepiness
A NA study of Sleep Deprivation and Sleep Wake Disorders, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03130803 is a NA study of Sleep Deprivation and Sleep Wake Disorders that has completed, run by University of Colorado, Boulder. The registered enrollment target is 12 participants, below the 91-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03130803, a NA study of Sleep Deprivation and Sleep Wake Disorders, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Sleep and wakefulness disorders impact 50 to 70 million Americans and insufficient sleep is epidemic with over 50% of Americans reporting less than 7 hours of sleep per night. Health problems associated with insufficient sleep include inflammation, depression and anxiety, diabetes, stress, drug abuse, poor quality of life, obesity, and fatigue related accidents on the job/while driving. While the contribution of sleep to overall health, well-being, and public safety is recognized, no established clinical biomarkers of sleep deficiency exist. Such biomarkers would have utility as road-side biomarkers of sleepiness (e.g., drowsy driving), monitoring on the job fatigue/fitness for duty (e.g., transportation, military ops health care), monitoring sleep health, as well as for clinical diagnostics and measures of clinical treatment outcomes. Thus, investigators designed a controlled laboratory insufficient sleep protocol utilizing metabolomics to identify biomarkers of insufficient sleep. Investigators propose to identify changes in metabolites that consistently occur during insufficient sleep. As an exploratory outcome investigators will examine associated changes in metabolites and cognitive performance during insufficient sleep.
Conditions Studied
Interventions
- BEHAVIORAL Insufficient Sleep
Study Locations (1)
Colorado
- Sleep and Chronobiology Laboratory - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-01-19 |
| Est. Completion | 2019-02-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03130803
The ClinicalTrials.gov registry entry for NCT03130803 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 34 other Sleep Deprivation trials with a reported enrollment target (87% lower). The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sleep Deprivation appearing as the primary indexed condition, and to 1 intervention - of which Insufficient Sleep is the first listed.
NCT03130803 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03130803 about?
NCT03130803 is a clinical study titled "Biomarkers of Insufficient Sleep and Sleepiness". Sleep and wakefulness disorders impact 50 to 70 million Americans and insufficient sleep is epidemic with over 50% of Americans reporting less than 7 hours of sleep per night. Health problems associated with insufficient sleep include inflammation, depression and anxiety, diabetes, stress, drug abus...
What is the current status of trial NCT03130803?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-01-19. Estimated completion is 2019-02-22.
What conditions does trial NCT03130803 study?
This clinical trial studies the following conditions: Sleep Deprivation, Sleep Wake Disorders, Insufficient Sleep Syndrome.
What interventions are being tested in trial NCT03130803?
The interventions under investigation include: Insufficient Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT03130803?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03130803 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Deprivation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biomarkers of Increased Free Living Sleep Time
RECRUITING · NA
-
The Function of Biphasic Sleep in Infants
RECRUITING · NA
-
Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep
RECRUITING · NA
-
Caffeine Optimization Versus Standard Caffeine Dosage (2B-2)
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
-
Menstrual-phase-dependent Differences in Response to Sleep Loss
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.